A rating of 24 puts GW Pharmaceuticals PLC- ADR (GWPH) near the bottom of the Drug Manufacturers - General industry according to InvestorsObserver. GW Pharmaceuticals PLC- ADR's score of 24 means it scores higher than 24% of stocks in the industry. GW Pharmaceuticals PLC- ADR also received an overall rating of 38, putting it above 38% of all stocks. Drug Manufacturers - General is ranked 20 out of the 148 industries.
What do These Ratings Mean?
Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. Investors Observer allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 38 would rank higher than 38 percent of all stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With GW Pharmaceuticals PLC- ADR Stock Today?
GW Pharmaceuticals PLC- ADR (GWPH) stock is up 3.46% while the S&P 500 has fallen -1.47% as of 2:06 PM on Tuesday, Sep 8. GWPH has gained $3.46 from the previous closing price of $100.09 on volume of 365,123 shares. Over the past year the S&P 500 is higher by 13.36% while GWPH has fallen -23.44%. GWPH lost -$1.79 per share the over the last 12 months.